HUMAN PAPILLOMAVIRUS TYPE-16-E6 INCREASES THE DEGRADATION RATE OF P53 IN HUMAN KERATINOCYTES

被引:169
作者
HUBBERT, NL [1 ]
SEDMAN, SA [1 ]
SCHILLER, JT [1 ]
机构
[1] NCI,CELLULAR ONCOL LAB,BETHESDA,MD 20892
关键词
D O I
10.1128/JVI.66.10.6237-6241.1992
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
The E6 proteins of the high-risk human papillomaviruses (HPVs) have been shown to form a complex with and induce the degradation of human p53 in vitro. To determine whether p53 is degraded more rapidly in cells expressing E6 in vivo, the half-life of p53 was determined by pulse-chase analysis in early-passage normal human keratinocytes and fibroblasts, human keratinocytes immortalized with HFV type 16 (HPV16) E6 plus E7, and nonimmortal keratinocytes transfected with E6. The results of these experiments indicate that (i) the half-life of newly synthesized p53 is relatively long (4 h) in early-passage human keratinocytes and fibroblasts but short in keratinocytes expressing E6 (15 to 30 min), (ii) a similar increased rate of p53 degradation was measured in lines immortalized with HPV16 E6 plus E7 and senescent cells expressing E6, indicating that this increase is not simply the result of selection in the immortalized lines, and (iii) very low levels of expression of E6 result in a greatly decreased half-life of p53, suggesting that E6 acts in a catalytic manner.
引用
收藏
页码:6237 / 6241
页数:5
相关论文
共 29 条
  • [1] IDENTIFICATION OF THE HPV-16 E6 PROTEIN FROM TRANSFORMED MOUSE CELLS AND HUMAN CERVICAL-CARCINOMA CELL-LINES
    ANDROPHY, EJ
    HUBBERT, NL
    SCHILLER, JT
    LOWY, DR
    [J]. EMBO JOURNAL, 1987, 6 (04) : 989 - 992
  • [2] SUPPRESSION OF HUMAN COLORECTAL-CARCINOMA CELL-GROWTH BY WILD-TYPE-P53
    BAKER, SJ
    MARKOWITZ, S
    FEARON, ER
    WILLSON, JKV
    VOGELSTEIN, B
    [J]. SCIENCE, 1990, 249 (4971) : 912 - 915
  • [3] LOSS OF P53 PROTEIN IN HUMAN PAPILLOMAVIRUS TYPE-16 E6-IMMORTALIZED HUMAN MAMMARY EPITHELIAL-CELLS
    BAND, V
    DECAPRIO, JA
    DELMOLINO, L
    KULESA, V
    SAGER, R
    [J]. JOURNAL OF VIROLOGY, 1991, 65 (12) : 6671 - 6676
  • [4] INVITRO BIOLOGICAL-ACTIVITIES OF THE E6 AND E7 GENES VARY AMONG HUMAN PAPILLOMAVIRUSES OF DIFFERENT ONCOGENIC POTENTIAL
    BARBOSA, MS
    VASS, WC
    LOWY, DR
    SCHILLER, JT
    [J]. JOURNAL OF VIROLOGY, 1991, 65 (01) : 292 - 298
  • [5] BARTEK J, 1991, ONCOGENE, V6, P1699
  • [6] DEGRADATION OF P53 CAN BE TARGETED BY HPV E6 SEQUENCES DISTINCT FROM THOSE REQUIRED FOR P53 BINDING AND TRANSACTIVATION
    CROOK, T
    TIDY, JA
    VOUSDEN, KH
    [J]. CELL, 1991, 67 (03) : 547 - 556
  • [7] CROOK T, 1991, ONCOGENE, V6, P873
  • [8] WILD-TYPE P53 CAN INHIBIT ONCOGENE-MEDIATED FOCUS FORMATION
    ELIYAHU, D
    MICHALOVITZ, D
    ELIYAHU, S
    PINHASIKIMHI, O
    OREN, M
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1989, 86 (22) : 8763 - 8767
  • [9] ACTIVATING MUTATIONS FOR TRANSFORMATION BY P53 PRODUCE A GENE-PRODUCT THAT FORMS AN HSC70-P53 COMPLEX WITH AN ALTERED HALF-LIFE
    FINLAY, CA
    HINDS, PW
    TAN, TH
    ELIYAHU, D
    OREN, M
    LEVINE, AJ
    [J]. MOLECULAR AND CELLULAR BIOLOGY, 1988, 8 (02) : 531 - 539
  • [10] THE P53 PROTO-ONCOGENE CAN ACT AS A SUPPRESSOR OF TRANSFORMATION
    FINLAY, CA
    HINDS, PW
    LEVINE, AJ
    [J]. CELL, 1989, 57 (07) : 1083 - 1093